Suppr超能文献

舒尼替尼衍生物对胶质母细胞瘤单细胞迁移和三维细胞培养的影响。

Effect of sunitinib derivatives on glioblastoma single-cell migration and 3D cell cultures.

作者信息

Dabkeviciute Girstaute, Maccioni Ellias, Petrikaite Vilma

机构信息

Institute of Biotechnology, Life Sciences Center, Vilnius University Sauletekio al. 7, LT-10257, Vilnius, Lithuania.

Laboratory of Drug Targets Histopathology, Institute of Cardiology, Lithuanian University of Health Sciences Sukileliu pr. 13, LT-50162, Kaunas, Lithuania.

出版信息

Am J Cancer Res. 2023 Apr 15;13(4):1377-1386. eCollection 2023.

Abstract

This study aimed to evaluate the anticancer activity of 16 new sunitinib derivatives in brain cancer cells (2D model) and spheroids (3D model). The effect on cell viability was determined by the MTT assay. Single-cell migration assay was performed to examine the effect of selected compounds on individual cell migration. The activity of compounds in 3D cell cultures was examined by measuring the size change of spheroids formed using the Hanging drop method. The viability of brain cancer (U-87MG and A-172) cells was most reduced by compound EMAC4001. EMAC4001 showed the strongest effect on U-87MG cell migration, and EMAC4007 was the most active in the A-172 cell line. Only sunitinib had a statistically significant impact on spheroid growth at 100 nM and 500 nM concentrations in the U87-MG cell line and EMAC4007 had a statistically significant impact on A-172 spheroid growth at 100 nM and 500 nM concentrations, similarly to sunitinib.

摘要

本研究旨在评估16种新的舒尼替尼衍生物在脑癌细胞(二维模型)和球体(三维模型)中的抗癌活性。通过MTT法测定对细胞活力的影响。进行单细胞迁移试验以检测所选化合物对单个细胞迁移的影响。通过测量使用悬滴法形成的球体大小变化来检测化合物在三维细胞培养中的活性。化合物EMAC4001对脑癌(U-87MG和A-172)细胞活力的降低作用最为明显。EMAC4001对U-87MG细胞迁移的影响最强,而EMAC4007在A-172细胞系中活性最高。在U87-MG细胞系中,仅舒尼替尼在100 nM和500 nM浓度下对球体生长有统计学显著影响,与舒尼替尼类似,EMAC4007在100 nM和500 nM浓度下对A-172球体生长有统计学显著影响。

相似文献

7
A three-dimensional in vitro HepG2 cells liver spheroid model for genotoxicity studies.一种用于遗传毒性研究的三维体外HepG2细胞肝球体模型。
Mutat Res Genet Toxicol Environ Mutagen. 2018 Jan;825:51-58. doi: 10.1016/j.mrgentox.2017.12.005. Epub 2017 Dec 15.

本文引用的文献

1
5
Recent advances in isatin hybrids as potential anticancer agents.色胺酮杂合体作为潜在抗癌剂的最新进展。
Arch Pharm (Weinheim). 2020 Mar;353(3):e1900367. doi: 10.1002/ardp.201900367. Epub 2020 Jan 21.
7
Isatin-azole hybrids and their anticancer activities.靛红-唑类杂合体及其抗癌活性。
Arch Pharm (Weinheim). 2020 Jan;353(1):e1900272. doi: 10.1002/ardp.201900272. Epub 2019 Nov 6.
9
Investigating the Anticancer Activity of Isatin/Dihydropyrazole Hybrids.研究异吲哚酮/二氢吡唑杂化物的抗癌活性。
ACS Med Chem Lett. 2018 Dec 18;10(4):571-576. doi: 10.1021/acsmedchemlett.8b00596. eCollection 2019 Apr 11.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验